Published in Gematol Transfuziol on April 01, 1983
The elimination peculiarities of perfluorocarbon emulsions stabilized with egg yolk phospholipid. Artif Cells Blood Substit Immobil Biotechnol (1994) 0.77
[Prediction of the effect of xenobiotics on human beings]. Farmakol Toksikol (1984) 0.75
Effect of perfluorochemical emulsion on lipoproteins of plasma blood. Artif Cells Blood Substit Immobil Biotechnol (1994) 0.75
[Immunomodulating properties of perfluorocarbon emulsions]. Gematol Transfuziol (1988) 0.75
[Fluorocarbons as possible oxygen-carrying blood substitutes]. Probl Gematol Pereliv Krovi (1981) 0.75
[Artificial blood--a new stage in the development of current transfusiology]. Probl Gematol Pereliv Krovi (1982) 0.75
[Fractionation of nonionogenic surface-active substances]. Probl Gematol Pereliv Krovi (1982) 0.75
[Preservation of an isolated kidney in normothermic conditions by perfluorotributylamine emulsion perfusion]. Biull Eksp Biol Med (1983) 0.75
[Body's oxygen supply after total blood substitution with organofluoric emulsions]. Gematol Transfuziol (1983) 0.75
[Biological properties of emulsions of organofluorine compounds as model oxygen-carrier blood substitutes]. Probl Gematol Pereliv Krovi (1979) 0.75
[Perfusion of the isolated heart using ftoksilol, an emulsion of perfluorocarbons]. Biull Eksp Biol Med (1982) 0.75
[Determination of fluorocarbons in organs by gas chromatography]. Probl Gematol Pereliv Krovi (1982) 0.75
[Comparative evaluation of thrombelastogram indices during testing of the emulsifying agents of perfluoroorganic compounds]. Gematol Transfuziol (1987) 0.75
[State of the microcirculation following total blood replacement with a model perfluorotributylamine-based blood substitute in rats]. Biull Eksp Biol Med (1980) 0.75
[Elimination of perfluorides of different classes with exhaled air after infusion of emulsions prepared on their base]. Gematol Transfuziol (1983) 0.75
Some aspects of perfluorochemical emulsion's interaction with blood. Biomater Artif Cells Immobilization Biotechnol (1992) 0.75
[Hematopoiesis in the dog in experiments with acute blood loss replaced by a PFC emulsion combined with polyglucin]. Patol Fiziol Eksp Ter (1985) 0.75
[Various aspects of the toxicologic aspects of alcohol]. Gematol Transfuziol (1987) 0.75
[Hematopoietic study of rats in experiments with exchange blood replacement by an emulsion of perfluorotributylamine]. Biull Eksp Biol Med (1979) 0.75
[Changes in blood clotting factors after exposing the blood to an emulsion of perfluoroorganic compounds]. Gematol Transfuziol (1986) 0.75
[Changes in lactate dehydrogenase activity and lactic and pyruvic acid concentration in the blood and tissues of animals following intravenous administration of perfluorotributylamine emulsions]. Vopr Med Khim (1981) 0.75
[Fatty acid composition of lipids absorbed by perfluorocompounds during their circulation in the blood vessels]. Gematol Transfuziol (1986) 0.75
[Use of perfucol--an oxygen-carrying blood substitute--in experimental parallel veno-arterial perfusion]. Gematol Transfuziol (1986) 0.75
[Effect of lipid emulsifiers on the properties of organoperfluorine emulsions]. Vestn Akad Med Nauk SSSR (1990) 0.75
[Prospects for the practical use of liposomes]. Gematol Transfuziol (1987) 0.75
[State of circulation and the body's oxygen supply following total blood replacement with perfluorotributylamine emulsion]. Biull Eksp Biol Med (1980) 0.75
[Kinetics of oxygen saturation of fluorocarbon emulsions]. Vopr Med Khim (1981) 0.75
[Perfusion protection of ischemic liver using perfluorocarbon emulsion]. Biull Eksp Biol Med (1990) 0.75
[Mechanism of the enhanced stability of emulsions of perfluoro-organic compounds in the circulatory bed]. Gematol Transfuziol (1987) 0.75
[Successive replacement of fatal blood loss in dogs with polyglucin and perfluorocarbon emulsion]. Biull Eksp Biol Med (1984) 0.75
[Comparative evaluation of the thromboelastogram indices in in vitro research on emulsions of perfluoro-organic compounds]. Gematol Transfuziol (1987) 0.75
[Organofluorine compounds as oxygen-carrier blood substitutes]. Probl Gematol Pereliv Krovi (1979) 0.75
[Liposomes--carriers of cytostatic preparations]. Gematol Transfuziol (1984) 0.75
[Use of donor albumin and polyglucin as hemodynamic ingredients in perfluorocarbon emulsions]. Gematol Transfuziol (1984) 0.75
[Anti-ischemic protection of the liver using perfluorocarbon emulsion]. Gematol Transfuziol (1989) 0.75
[Dynamics of arterial pressure and gas exchange in dogs with acute blood loss replaced by an emulsion of carbon tetrafluoride]. Gematol Transfuziol (1983) 0.75
[Various aspects of production of a therapeutic form of liposomal cytarabine]. Vestn Akad Med Nauk SSSR (1990) 0.75
[A modification of the bromsulphalein test for studying the excretory-absorptive function of the liver in rats]. Patol Fiziol Eksp Ter (1990) 0.75
[Gas chromatographic method of determining polydispersion in the staged centrifugation of perfluoro compound emulsions as bases for a complex oxygen-carrier blood substitute]. Probl Gematol Pereliv Krovi (1982) 0.75
[Gas exchange and blood circulation status in dogs following replacement of acute blood loss by perfluoro compound emulsions]. Biull Eksp Biol Med (1983) 0.75
[Possible increase in the duration of the circulation of perfluorodecalin emulsions in the vascular bed of rats]. Gematol Transfuziol (1988) 0.75
[Microcirculatory indices in the experimental therapy of acute blood loss using a blood substitute--an oxygen carrier based on perfluorodecalin]. Gematol Transfuziol (1983) 0.75
[Blood coagulation in dogs following the compensation of acute blood loss with polyglucin and an emulsion of perfluoro compounds]. Gematol Transfuziol (1988) 0.75
[Bases of the duration of a chronic experiment]. Gig Sanit (1991) 0.75
[Anti-arrhythmic action of a carbon tetrafluoride emulsion]. Biull Eksp Biol Med (1982) 0.75
Effect of lipid absorption by perfluorochemical emulsions in the bloodstream and perspectives of its clinical application. Artif Cells Blood Substit Immobil Biotechnol (1994) 0.75
[Non-ionogenic surface-active agents as a component of oxygen carrying fluorocarbon blood substitutes]. Probl Gematol Pereliv Krovi (1982) 0.75
[Prediction of safe doses of fluorocarbons at different rates of experimental administration]. Gematol Transfuziol (1987) 0.75
[Antileukemic activity of liposome forms of cytosine arabinoside and cyclocytidine]. Gematol Transfuziol (1984) 0.75